Literature DB >> 12815492

Health-related quality of life of cataract patients: cross-cultural comparisons of utility and psychometric measures.

Jae Eun Lee1, Peter J Fos, Miguel A Zuniga, Peter R Kastl, Jung Hye Sung.   

Abstract

BACKGROUND: This study was conducted to assess the presence and/or absence of cross-cultural differences or similarities between Korean and United States cataract patients. A systematic assessment was performed using utility and psychometric measures in the study population. RESEARCH
DESIGN: A cross-sectional study design was used to examine the comparison of preoperative outcomes measures in cataract patients in Korea and the United States. Study subjects were selected using non-probabilistic methods and included 132 patients scheduled for cataract surgery in one eye. PARTICIPANTS: Subjects were adult cataract patients at Samsung and Kunyang General Hospital in Seoul, Korea, and Tulane University Hospital and Clinics in New Orleans, Louisiana. MEASUREMENTS: Preoperative utility was assessed using the verbal rating scale and standard reference gamble techniques. Current preoperative health status was assessed using the SF-36 and VF-14 surveys. Current preoperative Snellen visual acuity was used as a clinical measure of vision status.
RESULTS: Korean patients were more likely to be younger (p = 0.001), less educated (p = 0.001), and to have worse Snellen visual acuity (p = 0.002) than United States patients. Multivariate analysis of variance (MANOVA) revealed that in contrast to Korean patients, United States patients were assessed to have higher scoring in general health, vitality, VF-14, and verbal rating for visual health. This higher scoring trend persisted after controlling for age, gender, education and Snellen visual acuity. The difference in health-related quality of life (HRQOL) between the two countries was quite clear, especially in the older age and highly educated group.
CONCLUSIONS: Subjects in Korea and the United States were significantly different in quality of life, functional status and clinical outcomes. Subjects in the United States had more favorable health outcomes than those in Korea. These differences may be caused by multiple factors, including country-specific differences in economic status, health care system, cultural value system, and health policy. Cross-cultural differences should be considered when making international comparisons of quality of life.

Entities:  

Mesh:

Year:  2003        PMID: 12815492     DOI: 10.1076/opep.10.3.177.15084

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  5 in total

1.  Relationship of cataract symptoms of preoperative patients and vision-related quality of life.

Authors:  Jae Eun Lee; Peter J Fos; Jung Hye Sung; Brian W Amy; Miguel A Zuniga; Won Jae Lee; Jae Chang Kim
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  The performance and publication of cost-utility analyses in plastic surgery: Making our specialty relevant.

Authors:  Achilleas Thoma; Teegan A Ignacy; Natalia Ziolkowski; Sophocles Voineskos
Journal:  Can J Plast Surg       Date:  2012

3.  Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.

Authors:  K G Au Eong; E W Chan; N Luo; S H Wong; N W H Tan; T H Lim; A M Wagle
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

4.  Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.

Authors:  Evans L Sagwa; Nunurai Ruswa; Farai Mavhunga; Timothy Rennie; Hubert Gm Leufkens; Aukje K Mantel-Teeuwisse
Journal:  Patient Prefer Adherence       Date:  2016-11-23       Impact factor: 2.711

5.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.